A Swiss database and biobank to better understand and manage congenital lung anomalies.
Vidal IDivision of Paediatric Surgery, Geneva University Hospital, University Centre of Paediatric Surgery of Western Switzerland, Geneva, Switzerland.
Wildhaber BEDivision of Paediatric Surgery, Geneva University Hospital, University Centre of Paediatric Surgery of Western Switzerland, Geneva, Switzerland / Division of Paediatric Surgery, Lausanne University Hospital, University Centre of Paediatric Surgery of Western Switzerland, Lausanne, Switzerland.
Moehrlen UDivision of Paediatric Pulmonology, Children's Hospital, St Gallen, Switzerland.
Regamey NDivision of Paediatric Pulmonology, Children's Hospital of Lucerne, Switzerland.
Trachsel DDivision of Intensive Care and Pulmonology, University of Basel Children's Hospital UKBB, Basel, Switzerland.
Cholewa DDepartment of Paediatric Surgery, Inselspital, University Hospital and University of Bern, Switzerland.
Barben JDepartment of Paediatric Surgery, Zurich Centre for Fetal Diagnosis and Therapy, University Children's Hospital Zurich, Zurich, Switzerland.
Barazzone-Argiroffo CDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland / Paediatric Pulmonology Unit, Department of Paediatrics, University Hospital Geneva, Switzerland.
Ruchonnet-Métrailler IDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Switzerland / Paediatric Pulmonology Unit, Department of Paediatrics, Geneva University Hospital, Switzerland.
English
Congenital lung anomalies are a group of rare malformations, often diagnosed during the prenatal period. Guidelines on how to manage these patients are currently under debate, especially with regard to prophylactic surgery in asymptomatic patients, or how to proceed with conservative follow-up. Currently, there is no clear consensus on management strategies. A Swiss congenital lung anomaly national database and biobank was created in 2016 to enable data recording and collection of surgical lung samples in order to help define the most appropriate management strategies. This national observational cohort study represents an important step towards a better understanding of the pathophysiology and clinical course of the diseases included under congenital lung anomalies, especially in the context of a small country like Switzerland.